carbamazepine has been researched along with bilirubin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Petruch, F; Schüppel, RV | 1 |
Callaghan, N; Duggan, B; O'Driscoll, D; O'Hare, JA | 1 |
Aggarwal, A; Faridi, MM; Kumar, M | 1 |
Aycicek, A; Iscan, A | 1 |
Fujii, H; Hatakeyama, N; Kanno, H; Kubo, N; Suzuki, N; Tachi, N; Tsutsumi, H; Yamamoto, M | 1 |
Berg, MJ; Braun, KP; Koudijs, SM; Malingré, MM; ter Heine, R; van der Westerlaken, MM; van Maarseveen, EM | 1 |
Burger, DM; Drenth, JPH; Jacobs, TG; Khoo, SH; Pranger, AD; van Crevel, R | 1 |
1 review(s) available for carbamazepine and bilirubin
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
1 trial(s) available for carbamazepine and bilirubin
Article | Year |
---|---|
Effect of carbamazepine on serum lipids and liver function tests.
Topics: Alkaline Phosphatase; Anticonvulsants; Bilirubin; Carbamazepine; Child; Child, Preschool; Cholesterol; Female; Humans; Lipids; Liver; Liver Function Tests; Male; Prospective Studies; Seizures; Triglycerides | 2005 |
8 other study(ies) available for carbamazepine and bilirubin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
[Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
Topics: Adult; Antipyrine; Bilirubin; Carbamazepine; Creatinine; Epilepsy; Female; Half-Life; Humans; Hydroxylation; Liver; Male; Middle Aged; Phenytoin; Time Factors; Trigeminal Neuralgia | 1975 |
Biochemical evidence for osteomalacia with carbamazepine therapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bilirubin; Carbamazepine; Child; Enzyme Induction; Epilepsy; Humans; Hypocalcemia; Liver; Osteomalacia; Phosphates | 1980 |
The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children.
Topics: Anticonvulsants; Antioxidants; Bilirubin; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Lipid Peroxides; Male; Oxidative Stress; Peroxides; Phenobarbital; Serum Albumin; Uric Acid; Valproic Acid | 2007 |
Carbamazepine-induced hemolytic and aplastic crises associated with reduced glutathione peroxidase activity of erythrocytes.
Topics: Anemia, Aplastic; Bilirubin; Carbamazepine; Child, Preschool; Enzyme Activation; Erythrocytes; Glutathione Peroxidase; Hemolysis; Humans; Lactate Dehydrogenases; Male; Molecular Structure; Reticulocytosis | 2007 |
The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
Topics: Adolescent; Anticonvulsants; Bilirubin; Carbamazepine; Child; Child, Preschool; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Male; Netherlands; Nonlinear Dynamics; Phenytoin; Protein Binding; Retrospective Studies; Serum Albumin; Urea; Valproic Acid | 2014 |
Carbamazepine intervention in a patient with efavirenz-induced liver injury.
Topics: Alanine Transaminase; Alkynes; Anti-HIV Agents; Aspartate Aminotransferases; Benzoxazines; Bilirubin; Carbamazepine; Chemical and Drug Induced Liver Injury; Cyclopropanes; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP3A Inducers; Humans; Male; Middle Aged; Treatment Outcome | 2019 |